The Key Ingredient Acacetin in Weishu Decoction Alleviates Gastrointestinal Motility Disorder Based on Network Pharmacology Analysis

Abstract

Background. Gastrointestinal motility disorder is a common gastrointestinal disease, which seriously affects life quality. Traditional Chinese medicine (TCM) has been widely used as an alternative therapy for gastrointestinal motility disorder. Acacetin is a natural flavonoid compound that has antioxidant and anti-inflammatory, antidepressant, and anticancer properties. However, the efficacy of Acacetin in the treatment of gastrointestinal motility disorders has not been studied. Our aim was to investigate the mechanism of Acacetin-alleviated gastrointestinal motility disorder and its efficacy based on network pharmacology. Methods. We performed network pharmacology to predict the active components, match Weishu decoction (WSD) targets in gastrointestinal motility disorders, and investigate its potential pharmacological mechanisms. We performed the GO and KEGG enrichment analysis. In vivo, we investigated the effects of Acacetin in the gastrointestinal motility disorder model. Results. Based on network pharmacological method, the key active ingredient of WSD was identified as Acacetin, and the enrichment signaling pathway was the PI3K-AKT signaling pathway. Acacetin and Mosapride accelerated gastric emptying time, reduced gastric remnant rate, and increased small intestinal propulsion rate. The levels of GAS and MTL were increased after using Acacetin. These results indicated that Acacetin could improve gastrointestinal motility disorders. Among them, high-dose Acacetin showed a better effect. Acacetin could regulate protein and lipid metabolism in mice with gastrointestinal motility disorder. Furthermore, Acacetin could modulate gastrointestinal inflammation and apoptosis. The detection of the PI3K-AKT signaling pathway-related proteins showed that Acacetin improved gastrointestinal motility disorder by inhibiting the activation of the PI3K-AKT signaling pathway. Conclusion. The key ingredient Acacetin in WSD could alleviate gastrointestinal motility disorder by inhibiting the activation of the PI3K-AKT signaling pathway based on network pharmacology analysis. The efficacy and safety of Acacetin treatment provide strong experimental support for the clinical treatment of gastrointestinal motility disorder.

Protective effect and mechanism of Polygonatum kingianum against hypoxia-induced injury

“…PK active ingredient targets and hypoxic targets were analyzed through Venn ( http://bioinformatics.psb.ugent.be/webtools/Venn/ ). The "drug - active ingredient - targets - disease" network diagram was established using Cytoscape3.8.2, and the results were visualized [ 29 , 30 ].…”

The Probiotic Combination of Lacticaseibacillus paracasei JY062 and Lactobacillus gasseri JM1 Alleviates Gastrointestinal Motility Disorder via Improving Gut Microbiota

“…Before being sacrificed, the mice were fasted for 24 h. Then, they were intragastrically administered 0.5 mL of ink and sacrificed 30 min later. The determination of the gastric emptying rate and small intestine propulsive rate was slightly modified from previous methods [ 20 ]. (1) Weighed the ink weight ( a 1 ) and total stomach weight ( a 2 ).…”

Mechanism of acacetin regulating hepatic stellate cell apoptosis based on network pharmacology and experimental verification

“…For example, based on network pharmacology and experimental validation analysis, acacetin can fight sepsis through multiple targets and pathways [ 16 ]. Acacetin was shown to be a key component in Weishu decoction and could alleviate gastrointestinal motility disorders by inhibiting the activation of the PI3K-AKT signaling pathway by network pharmacology analysis [ 17 ]. In this study, we used network pharmacology combined with molecular docking and experimental validation (The measurement parameters including α-SMA, COL1A1, CASPASE-3, -8, -9, BAX, BCL2, PARP1 and TP53) to investigate the potential targets of acacetin in hepatic fibrosis and to verify the regulatory mechanism by which acacetin improves hepatic fibrosis.…”